Papers
2
Total Citations
10
H-Index
2
About
Dr. Hind Rafei is a leading oncologist whose research focuses on de-escalating treatment for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her major contribution is pioneering a novel therapeutic strategy that combines induction chemotherapy with transoral robotic surgery (TORS) as definitive treatment, aiming to spare patients the lifelong morbidity associated with standard chemoradiation. Her two most-cited Phase II studies (each with 5 citations) directly challenge the conventional paradigm by demonstrating the efficacy of this less toxic, surgery-first approach for locally advanced OPSCC. This work has significant implications for improving quality of life in survivors, reducing severe side effects like swallowing dysfunction and xerostomia. Dr. Rafei’s research is at the forefront of personalized, function-preserving oncology, offering a promising alternative that could reshape standard care. Her dedication to minimizing treatment toxicity while maintaining excellent oncologic outcomes marks her as an innovator in head and neck cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2